Literature DB >> 29158162

The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.

M-J Hannocks1, X Zhang1, H Gerwien1, A Chashchina1, M Burmeister1, E Korpos1, J Song1, L Sorokin2.   

Abstract

This review focuses on the complementary roles of MMP-2 and MMP-9 in leukocyte migration into the brain in neuroinflammation, studied mainly in a murine model of experimental autoimmune encephalomyelitis (EAE) that has similarity to the human disease multiple sclerosis. We discuss the cellular sources of MMP-2/MMP-9 in EAE, their sites of activity, and how cleavage of the to-date identified MMP-2/MMP-9 substrates at the blood-brain barrier facilitate leukocyte filtration of the central nervous system (CNS). Where necessary, comparisons are made to inflammatory processes in the periphery and to other MMPs relevant to neuroinflammation. While the general principles concerning MMP-2 and MMP-9 function discussed here are relevant to all inflammatory situations, the details regarding substrates and molecular mechanisms of action are likely to be specific for neuroinflammation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MMP-2 and MMP-9; Neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 29158162     DOI: 10.1016/j.matbio.2017.11.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  36 in total

1.  A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis.

Authors:  Bodhraj Acharya; Rakeshchandra R Meka; Shivaprasad H Venkatesha; Jason R Lees; Tambet Teesalu; Kamal D Moudgil
Journal:  Mol Cell Probes       Date:  2020-02-05       Impact factor: 2.365

2.  DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain.

Authors:  Han Wang; Yi-Jia Shen; Xiu-Juan Li; Jun Xia; Li Sun; Yehao Xu; Yu Ma; Dai Li; Yuan-Chang Xiong
Journal:  Neurochem Res       Date:  2021-02-06       Impact factor: 3.996

Review 3.  The emerging role of neutrophils as modifiers of recovery after traumatic injury to the developing brain.

Authors:  Ramona E von Leden; Kaila N Parker; Adrian A Bates; Linda J Noble-Haeusslein; Michael H Donovan
Journal:  Exp Neurol       Date:  2019-03-12       Impact factor: 5.330

4.  Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.

Authors:  Hideaki Nishihara; Britta Engelhardt
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Liquid Biopsy-Based Biomarkers of Inflammatory Nociception Identified in Male Rats.

Authors:  Christina R Merritt; Irma E Cisneros; Obdulia Covarrubias-Zambrano; Sonja J Stutz; Massoud Motamedi; Stefan H Bossmann; Kathryn A Cunningham
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

7.  Icariside II attenuates cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1.

Authors:  Mu-Bo Liu; Wei Wang; Jian-Mei Gao; Fei Li; Jing-Shan Shi; Qi-Hai Gong
Journal:  Acta Pharmacol Sin       Date:  2020-06-02       Impact factor: 6.150

Review 8.  Matrix metalloproteinases and inhibitors in dentistry.

Authors:  Gerd-Jan Boelen; Lucas Boute; Joëy d'Hoop; Mostafa EzEldeen; Ivo Lambrichts; Ghislain Opdenakker
Journal:  Clin Oral Investig       Date:  2019-05-15       Impact factor: 3.573

Review 9.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 10.  Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.

Authors:  Lidia Ciccone; Jennifer Vandooren; Susanna Nencetti; Elisabetta Orlandini
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.